Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC)

United States of America (USA)

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
5 0.48

Outputs by subject (Share)

Subject Count Share
Life Sciences 5 0.48
2 0.19
Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma
2020-05-15
0.07
Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer
2020-01-01
0.13
3 0.29

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 23.51% Domestic
  • 76.49% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs